This study emphasizes CYP4B1, CYP4F12, and CYP4F3 gene expression levels, presenting tumor versus normal tissue analysis, their expression adjusted by stages, their correlation with BRCA1, BRCA2, and ESR1, the estrogen receptor status, and the overall survival analysis in breast cancer patients. This evidence concerns the gene CYP4F3 and breast carcinoma.